SAFETY AND TOLERABILITY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF INFECTION RISK AND HEMATOLOGICAL CHANGES

被引:0
|
作者
Muppidi, Srikanth
Pasnoor, Mamatha
Gelinas, Deborah
Brauer, Edward
Kerstens, Rene
Bhavaraju-Sanka, Ratna
Howard, James
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
193
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
  • [41] Efgartigimod treatment for generalized myasthenia gravis: a single-center case series of 16 patients
    Nomura, Toshiya
    Imamura, Michie
    Imura, Masao
    Mizutani, Hironori
    Ueda, Mitsuharu
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [42] LONG-TERM ASSESSMENT OF EFGARTIGIMOD IN PATIENTS WITH GENERALISED MYASTHENIA GRAVIS: ADAPT plus STUDY INTERIM RESULTS
    Jacob, Saiju
    Howard, James
    Bril, Vera
    Peric, Stojan
    De Bleecker, Jan
    T'joen, Carolin
    Travers, Jackalyne
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [43] SAFETY AND EFFICACY OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Katzberg, Hans
    Idiaquez, Juan
    Mendoza, Meg
    Barnett, Carolina
    Huszti, Ella
    Lovblom, Erik
    Wang, Stella
    Bril, Vera
    MUSCLE & NERVE, 2024, 70 (03) : 683 - 683
  • [44] Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis
    Ruan, Zhe
    Tang, Yonglan
    Gao, Ting
    Li, Chunhong
    Guo, Rongjing
    Sun, Chao
    Huang, Xiaoxi
    Li, Zhuyi
    Chang, Ting
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (06)
  • [45] Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis
    Smith, A. Gordon
    Wolfe, Gil I.
    Habib, Ali A.
    Qi, Cynthia Z.
    Yang, Hongbo
    Du, Mandy
    Chen, Xin
    Gelinas, Deborah
    Brauer, Edward
    Phillips, Glenn
    Sacca, Francesco
    ADVANCES IN THERAPY, 2024, 41 (12) : 4628 - 4647
  • [46] Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis
    Li, George
    Li, Yuebing
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Casey, Jenna
    Noukens, Jan
    Van Bragt, Tonke
    Utsugisawa, Kimiaki
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    Howard, James
    NEUROLOGY, 2023, 100 (17)
  • [47] DOSE SELECTION AND CLINICAL DEVELOPMENT OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Guptill, Jeffrey
    Li, Yuebing
    Vu, Tuan
    Korobko, Denis
    Liu, Li
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Brauer, Eddie
    Noukens, Jan
    Van Bragt, Tonke
    Utsugisawa, Kimiaki
    De Bleecker, Jan L.
    Howard, James
    MUSCLE & NERVE, 2024, 70 (03) : 705 - 705
  • [48] Risk of Infection in Patients with Myasthenia Gravis With and Without Thymoma
    Clifford, Katherine
    McKeen, Will
    Yuan, Ye
    Muppidi, Srikanth
    NEUROLOGY, 2023, 100 (17)
  • [49] LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD PH20 SC IN GENERALIZED MYASTHENIA GRAVIS: INTERIM ANALYSIS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY SERONEGATIVE PARTICIPANTS IN ADAPT-SC
    Bhavaraju-Sanka, Ratna
    Howard, James F., Jr.
    Vu, Tuan
    De Bleecker, Jan L.
    Utsugisawa, Kimiaki
    Pasnoor, Mamatha
    Sacca, Francesco
    Korobko, Denis
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Liu, Li
    Podhorna, Jana
    Meisel, Andreas
    Mantegazza, Renato
    MUSCLE & NERVE, 2024, 70 (03) : 516 - 517
  • [50] A Study to Evaluate Efficacy, Safety and Tolerability of Single Doses of Tirasemtiv in Patients with Myasthenia Gravis
    Sanders, Donald
    Rosenfeld, Jeffrey
    Dimachkie, Mazen
    Meng, Lisa
    Malik, Fady
    NEUROLOGY, 2013, 80 (19) : E203 - E203